Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands		Total	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest	Cross currency swap	Cross currency swap Total	Cross currency swap Accumulated Other Comprehensive Income (Loss)	Interest rate swap	Interest rate swap Total	Interest rate swap Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Dec. 31, 2023				60,359
Balance at the start of the period at Dec. 31, 2023		$ 2,440,987	$ 2,315,427	$ 60	$ 1,614,769	$ (17,964)	$ 719,894	$ (1,332)	$ 125,560
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,769	4,769		4,769
Exercise of stock-based awards by employees and directors (in shares)	[1]			63
Exercise of stock-based awards by employees and directors	[1]	55	55		55
Cash paid to noncontrolling interest		(2,587)							(2,587)
Cash dividend declared		(7,243)	(7,243)				(7,243)
Net income		40,511	38,587				38,587		1,924
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		(2,163)	(1,701)					(1,701)	(462)
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		510	510					510
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge										$ 561	$ 561	$ 561	$ 1,066	$ 1,066	$ 1,066
Other		53	53					53
Balance (in shares) at Mar. 31, 2024				60,422
Balance at the end of the period at Mar. 31, 2024		2,476,519	2,352,084	$ 60	1,619,593	(17,964)	751,238	(843)	124,435
Balance (in shares) at Dec. 31, 2024				60,501
Balance at the start of the period at Dec. 31, 2024		2,550,932	2,425,129	$ 61	1,635,245	(17,964)	814,518	(6,731)	125,803
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,911	4,911		4,911
Exercise of stock-based awards by employees and directors (in shares)	[1]			162
Exercise of stock-based awards by employees and directors	[1]	754	754		754
Cash paid to noncontrolling interest		(2,767)							(2,767)
Cash dividend declared		(7,273)	(7,273)				(7,273)
Net income		41,317	40,362				40,362		955
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		2,761	2,183					2,183	578
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		(896)	(896)					(896)
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge										$ (3,466)	$ (3,466)	$ (3,466)	$ (512)	$ (512)	$ (512)
Other		12	12					12
Balance (in shares) at Mar. 31, 2025				60,663
Balance at the end of the period at Mar. 31, 2025		$ 2,585,773	$ 2,461,204	$ 61	$ 1,640,910	$ (17,964)	$ 847,607	$ (9,410)	$ 124,569

[1] Resulted in an amount lower than $1,000.